IMU due to a great CF33 anns and RAD due to Hopper becoming a subholder again are getting a little bit Sp-TLC today, maybe CHM gets a bit of a slipstream momentum. Nothing wrong on the clinical fronts at all but the market treats the 3 comps like crap. So far we have relied on management anns but any FDA decision pro any of the platforms should be seen as a confirmation even when the markets and pharma aren't willing or able to recognise it.
One day the sp will fly, but will I be still alive?
GLTA
IMU due to a great CF33 anns and RAD due to Hopper becoming a...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.40M | |||
| Open | High | Low | Value | Volume |
| 1.6¢ | 1.6¢ | 1.5¢ | $12.86K | 814.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 2026778 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 209581 | 6 |
View Market Depth
| Last trade - 13.50pm 18/09/2024 (20 minute delay) ? |
| CHM (ASX) Chart |